Get started
Award

20001891/np0025517

Funded outputs count: 24
Funder award ID: 20001891/NP0025517
OpenAlex ID: G7621673610
A historical journey of metabolite–protein interaction discovery: from data harmonization to AI-driven prediction
2026 · Toby Lawrence, Ema Mocsonokyova, et al. · Briefings in Bioinformatics
A gut microbiome-kidney-heart axis predictive of future cardiovascular diseases
2026 · Kanta Chechi, Rima Chakaroun, et al. · Nature Communications · 4
ERAP2 inhibitor −incorporated nanofibers: Characterization and biological assessment
2026 · Filipa Vasconcelos, Laetitia Lesire, et al. · International Journal of Pharmaceutics · 2
Prominent mediatory role of gut microbiome in the effect of lifestyle on host metabolic phenotypes
2025 · Solia Adriouch, Eugeni Belda, et al. · Gut Microbes · 2
Development of explicit definitions of potentially inappropriate prescriptions for antidiabetic drugs in people with type 2 diabetes: A Delphi survey and consensus meeting
2025 · Erwin Gerard, Derya Bugday, et al. · PLoS ONE · 1
PDF
Exploring the role of readthrough-inducing molecule 2,6-diaminopurine to increase immune response against cancer cells
2025 · Carmen Sandoval Pacheco, Alice M. Leroy, et al. · Molecular Therapy · 2
Observational study of demographics and glycemia control in inpatients with type 2 diabetes: Challenges and clinical implications
2025 · Madleen Lemaitre, Paul Quindroit, et al. · Annales d Endocrinologie · 1
Intrahepatic levels of microbiome-derived hippurate associates with improved metabolic dysfunction-associated steatotic liver disease
2024 · Maxime Deslande, Francesc Puig-Castellvi, et al. · Molecular Metabolism · 10
Home self-management of type 2 diabetes with diabetes technologies in northern France: a focused ethnographic study protocol
2024 · Romaric Marcilly, Paul Quindroit, et al. · BMJ Open
PDF
System engineering approach of the home self-management of type 2 diabetes: a work in progress
2024 · Romaric Marcilly, Justine Forrierre, et al. · European Conference on Cognitive Ergonomics · 1
PDF
Development of explicit definitions of potentially inappropriate prescriptions for antidiabetic drugs in patients with type 2 diabetes: A multidisciplinary qualitative study
2024 · Erwin Gerard, Paul Quindroit, et al. · PLoS ONE · 1
Usability Checklists for Health Technology: Case Study and Experts’ Opinions
2024 · Romaric Marcilly, Helen Monkman, et al. · Studies in health technology and informatics
Evidence of a causal and modifiable relationship between kidney function and circulating trimethylamine N-oxide
2023 · Petros Andrikopoulos, Judith Aron-Wisnewsky, et al. · Nature Communications · 85
PDF
Implementation of a clinical decision support system for the optimization of antidiabetic drug orders by pharmacists
2023 · Laurine Robert, Paul Quindroit, et al. · British Journal of Clinical Pharmacology · 9
PDF
Advances in the integration of metabolomics and metagenomics for human gut microbiome and their clinical applications
2023 · Francesc Puig-Castellví, Romina Pacheco-Tapia, et al. · TrAC Trends in Analytical Chemistry · 78
Description of a French Population of Diabetics Treated Followed up by General Practitioners
2023 · Mathilde Fruchart, Antoine Lamer, et al. · Studies in health technology and informatics · 2
PDF
Inter-Professional Communications During Follow-Up of Type 2 Diabetes Patients: An Exploratory Study
2023 · Romaric Marcilly, Madleen Lemaitre, et al. · Studies in health technology and informatics · 2
Heterozygous pathogenic variants in POMC are not responsible for monogenic obesity: Implication for MC4R agonist use
2023 · Lauriane Le Collen, Brigitte Delemer, et al. · Genetics in Medicine · 25
PDF
Defining explicit definitions of potentially inappropriate prescriptions for antidiabetic drugs in patients with type 2 diabetes: A systematic review
2022 · Erwin Gerard, Paul Quindroit, et al. · PLoS ONE · 5
PDF
Microbiome and metabolome features of the cardiometabolic disease spectrum
2022 · Sebastien Fromentin, Sofia K. Forslund, et al. · Nature Medicine · 282
PDF
Combinatorial, additive and dose-dependent drug–microbiome associations
2021 · Sofia K. Forslund, Rima Chakaroun, et al. · Nature · 227
Defining Potentially Inappropriate Prescriptions for Hypoglycaemic Agents to Improve Computerised Decision Support: A Study Protocol
2021 · Paul Quindroit, Nicolas Baclet, et al. · Healthcare · 5
PDF
Human and preclinical studies of the host–gut microbiome co-metabolite hippurate as a marker and mediator of metabolic health
2021 · François Brial, Julien Chilloux, et al. · Gut · 141
PDF
Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome
2021 · Jordi Mayneris-Perxachs, Marina Cardellini, et al. · Microbiome · 139
PDF
Year
Topic